261 related articles for article (PubMed ID: 38474142)
21. HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas.
Muscatello LV; Gobbo F; Di Oto E; Sarli G; De Maria R; De Leo A; Tallini G; Brunetti B
Vet Sci; 2022 Oct; 9(11):. PubMed ID: 36356060
[TBL] [Abstract][Full Text] [Related]
22. Advances and challenges of CAR T therapy and suitability of animal models (Review).
Ramos-Cardona XE; Luo W; Mohammed SI
Mol Clin Oncol; 2022 Sep; 17(3):134. PubMed ID: 35949897
[TBL] [Abstract][Full Text] [Related]
23. Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study.
Papparella S; Crescio MI; Baldassarre V; Brunetti B; Burrai GP; Cocumelli C; Grieco V; Iussich S; Maniscalco L; Mariotti F; Millanta F; Paciello O; Rasotto R; Romanucci M; Sfacteria A; Zappulli V
Vet Sci; 2022 Jul; 9(7):. PubMed ID: 35878374
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological Investigation of Canine Mammary Tumors in Mainland China Between 2017 and 2021.
Zheng HH; Du CT; Yu C; Zhang YZ; Huang RL; Tang XY; Xie GH
Front Vet Sci; 2022; 9():843390. PubMed ID: 35812867
[TBL] [Abstract][Full Text] [Related]
25. Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy.
Mpekris F; Voutouri C; Panagi M; Baish JW; Jain RK; Stylianopoulos T
J Control Release; 2022 May; 345():190-199. PubMed ID: 35271911
[TBL] [Abstract][Full Text] [Related]
26. Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study.
Vafaei R; Samadi M; Hosseinzadeh A; Barzaman K; Esmailinejad M; Khaki Z; Farahmand L
Cancer Cell Int; 2022 Jan; 22(1):14. PubMed ID: 35000604
[TBL] [Abstract][Full Text] [Related]
27. Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours.
Gedon J; Wehrend A; Kessler M
Vet Comp Oncol; 2022 Jun; 20(2):476-483. PubMed ID: 34913241
[TBL] [Abstract][Full Text] [Related]
28. Fucoxanthin Exerts Anti-Tumor Activity on Canine Mammary Tumor Cells via Tumor Cell Apoptosis Induction and Angiogenesis Inhibition.
Jang H; Choi J; Park JK; Won G; Seol JW
Animals (Basel); 2021 May; 11(6):. PubMed ID: 34071074
[TBL] [Abstract][Full Text] [Related]
29. Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity.
Gong Y; Klein Wolterink RGJ; Gulaia V; Cloosen S; Ehlers FAI; Wieten L; Graus YF; Bos GMJ; Germeraad WTV
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070311
[TBL] [Abstract][Full Text] [Related]
30. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review.
Valdivia G; Alonso-Diez Á; Pérez-Alenza D; Peña L
Front Vet Sci; 2021; 8():623800. PubMed ID: 33681329
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of immunohistopathological profile of tubular and solid canine mammary carcinomas.
Borghesi J; Giancoli Kato Cano da Silva M; de Oliveira Pimenta Guimarães K; Mario LC; de Almeida da Anunciação AR; Silveira Rabelo AC; Gonçalves Hayashi R; Lima MF; Miglino MA; Oliveira Favaron P; Oliveira Carreira AC
Res Vet Sci; 2021 May; 136():119-126. PubMed ID: 33609969
[TBL] [Abstract][Full Text] [Related]
32. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.
Supplitt S; Karpinski P; Sasiadek M; Laczmanska I
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572595
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Mucin 1 Suppresses the Therapeutical Efficacy of Disulfiram against Canine Mammary Tumor.
Zhao Y; Lin Z; Lin Z; Zhou C; Liu G; Lin J; Zhang D; Lin D
Animals (Basel); 2020 Dec; 11(1):. PubMed ID: 33375426
[TBL] [Abstract][Full Text] [Related]
34. The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology.
Gray M; Meehan J; Turnbull AK; Martínez-Pérez C; Kay C; Pang LY; Argyle DJ
Front Vet Sci; 2020; 7():598338. PubMed ID: 33282935
[TBL] [Abstract][Full Text] [Related]
35. A review on development of MUC1-based cancer vaccine.
Gao T; Cen Q; Lei H
Biomed Pharmacother; 2020 Dec; 132():110888. PubMed ID: 33113416
[TBL] [Abstract][Full Text] [Related]
36. A Statistical Analysis of Risk Factors and Biological Behavior in Canine Mammary Tumors: A Multicenter Study.
Burrai GP; Gabrieli A; Moccia V; Zappulli V; Porcellato I; Brachelente C; Pirino S; Polinas M; Antuofermo E
Animals (Basel); 2020 Sep; 10(9):. PubMed ID: 32961915
[TBL] [Abstract][Full Text] [Related]
37. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
[TBL] [Abstract][Full Text] [Related]
38. Identification of potential canine mammary tumour cell biomarkers using proteomic approach: Differences in protein profiles among tumour and normal mammary epithelial cells by two-dimensional electrophoresis-based mass spectrometry.
Fhaikrue I; Srisawat W; Nambooppha B; Pringproa K; Thongtharb A; Prachasilchai W; Sthitmatee N
Vet Comp Oncol; 2020 Dec; 18(4):787-795. PubMed ID: 32421920
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.
Prado MCM; Macedo SAL; Guiraldelli GG; de Faria Lainetti P; Leis-Filho AF; Kobayashi PE; Laufer-Amorim R; Fonseca-Alves CE
Front Oncol; 2019; 9():1445. PubMed ID: 31921690
[TBL] [Abstract][Full Text] [Related]
40. Prognostic phenotypic classification for canine mammary tumors.
Varallo GR; Gelaleti GB; Maschio-Signorini LB; Moschetta MG; Lopes JR; De Nardi AB; Tinucci-Costa M; Rocha RM; De Campos Zuccari DAP
Oncol Lett; 2019 Dec; 18(6):6545-6553. PubMed ID: 31807173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
